Loading...
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
SIMPLE SUMMARY: Antiplatelet therapy shows antitumor effect in several types of cancers. In liver disease, antiplatelet therapy reduces liver fibrosis and occurrence of HCC. However, the effect after diagnosis of hepatocellular carcinoma is still unknown. Therefore, we aimed to clarify the effects o...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693153/ https://ncbi.nlm.nih.gov/pubmed/33142758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|